Skip to main content
. 2007 Jul 16;110(8):3015–3027. doi: 10.1182/blood-2006-12-061507

Table 7.

Genes up- and down-regulated in patients with poor response to treatment

Gene symbol Gene name Fold change P FDR
In patients with poor response to treatment
    IL21R Interleukin-21 receptor 2.81 < .001 .048
    MYO7A Myosin VIIA (usher syndrome 1B [autosomal recessive, severe]) 2.44 < .001 .048
    RGS16 Regulator of G-protein signaling 16 2.29 < .001 < .001
    ANP32E Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E 2.00 < .001 < .001
    SLA Src-like adaptor 1.91 < .001 .048
    PPP1R16B Protein phosphatase 1, regulatory (inhibitor) subunit 16B 1.79 < .001 .048
    C1GALT1 Core 1 synthase 1.64 < .001 .048
    IL10 Interleukin-10 1.60 < .001 < .001
    TRIB2 Tribbles homolog 2 (Drosophila) 1.55 < .001 < .001
    MTHFD2 Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase 1.51 < .001 < .001
    EHD1 EH-domain containing 1 1.51 < .001 < .001
In patients with good response to treatment
    WIF1 WNT inhibitory factor 1 4.02 < .001 .048
    KRT15 Keratin 15 1.92 < .001 < .001
    GSTA3 Glutathione S-transferase A3 1.87 < .001 .048
    PTN Pleiotrophin (heparin-binding growth factor 8, neurite growth-promoting factor 1) 1.79 < .001 .048

Shown are genes with fold change greater than or equal to 1.5, P value less than or equal to .05, and FDR less than or equal to 0.05.